Literature DB >> 7458602

Fracture healing under factor XIII medication.

O Hellerer, W L Brückner, K W Frey, K W Westerburg, U Klessinger.   

Abstract

Following application of factor XIII for 3 weeks bone healing was studied in Sprague-Dawley rats on the 20th postoperatively day qualitatively (radiographs, scintigraphy) and quantitatively (determination of callus thickness, of bone mineral content, and scintillation counting). No significant difference could be detected between animals treated with factor XIII and animals which served as controls. Therefore, a stimulating effect of factor XIII upon bone healing can not be expected in case of a normal factor XIII serum-level. The application of factor XIII is indicated only in high risk patients with a low factor XIII serum-level.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7458602     DOI: 10.1007/bf00450939

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  5 in total

1.  The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing.

Authors:  E BECK; F DUCKERT; M ERNST
Journal:  Thromb Diath Haemorrh       Date:  1961-12-15

2.  [Model for the study of influences on fracture healing. Animal experiments].

Authors:  O Hellerer; W L Brückner; R Aigner; K W Westerburg; J Kleinschmidt
Journal:  Chir Forum Exp Klin Forsch       Date:  1979

3.  Experimental studies on fracture healing. 3. Accelerated fracture healing through soluble heterologous collagen.

Authors:  J Benfer; H Struck
Journal:  Arch Surg       Date:  1973-06

4.  [Animal experiments on the modification of fracture healing by growth hormone (STH)].

Authors:  G Senk; H Peters; K W Zilkens; J E Bubenzer; J van Wersch
Journal:  Chir Forum Exp Klin Forsch       Date:  1978

5.  Factor XIII and fracture healing. An experimental study.

Authors:  J Benfer; H Struck
Journal:  Eur Surg Res       Date:  1977       Impact factor: 1.745

  5 in total
  2 in total

1.  Osteopromotion with a plasmatransglutaminase on a beta-TCP ceramic.

Authors:  Stephan Becker; Otto Maissen; Igor Ponomarev; Thierry Stoll; Thomas Meury; Christoph Sprecher; Mauro Alini; Ingo Wilke
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

2.  Mild Acquired Factor XIII Deficiency and Clinical Relevance at the ICU-A Retrospective Analysis.

Authors:  Felix Carl Fabian Schmitt; Maik von der Forst; Wolfgang Miesbach; Sebastian Casu; Markus Alexander Weigand; Sonja Alesci
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.